{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:32:00Z","timestamp":1791653520178,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bioorg.2024.107154","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T21:33:54Z","timestamp":1706823234000},"page":"107154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity"],"prefix":"10.1016","volume":"144","author":[{"given":"Marwa M.","family":"Abdelhakeem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha M","family":"Morcoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina A.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phoebe F.","family":"Lamie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107154_b0005","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1038\/s41598-022-21024-7","article-title":"Synthesis and anticancer activity of new benzensulfonamides incorporating s\u2013triazines as cyclic linkers for inhibition of carbonic anhydrase IX","volume":"12","author":"Zain-Alabdeen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107154_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112439","article-title":"Expanding the anticancer potential of 1, 2, 3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases","volume":"200","author":"Elzahhar","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129735","article-title":"Structural investigation of isatin-based benzenesulfonamides as carbonic anhydrase isoform IX inhibitors endowed with anticancer activity using molecular modeling approaches","volume":"1229","author":"Abdizadeh","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107154_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103839","article-title":"Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids","volume":"99","author":"Singh","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0025","article-title":"Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors","volume":"239","author":"Buza","year":"2023","journal-title":"Int. J. Bio. Mac."},{"key":"10.1016\/j.bioorg.2024.107154_b0030","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ejmech.2015.04.033","article-title":"Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives","volume":"96","author":"Awadallah","year":"2015","journal-title":"Eur. J. Med."},{"key":"10.1016\/j.bioorg.2024.107154_b0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/14756366.2018.1446432","article-title":"Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails","volume":"33","author":"Awadallah","year":"2018","journal-title":"J. Enzyme. Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0040","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115538","article-title":"Design and synthesis of 6-arylpyridine-tethered sulfonamides as novel selective inhibitors of carbonic anhydrase IX with promising antitumor features toward the human colorectal cancer","volume":"258","author":"Eldehna","year":"2023","journal-title":"Eur. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/14756366.2018.1559840","article-title":"Phaeodactylum tricornutum as a model organism for testing the membrane penetrability of sulphonamide carbonic anhydrase inhibitors","volume":"34","author":"Rogato","year":"2019","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0055","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett.."},{"key":"10.1016\/j.bioorg.2024.107154_b0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/14756366.2014.956310","article-title":"Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII)","volume":"30","author":"Scozzafava","year":"2015","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0065","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/14756366.2014.999236","article-title":"The impact of hydroquinone on acetylcholine esterase and certain human carbonic anhydrase isoenzymes (hCA I, II, IX, and XII)","volume":"30","author":"Scozzafava","year":"2015","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112219","article-title":"Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes","volume":"193","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0075","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1021\/jm9014026","article-title":"Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme\u2013ligand X-ray studies","volume":"53","author":"Gitto","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators nature revi","volume":"7","author":"Supuran","year":"2008","journal-title":"Drug. Discov."},{"key":"10.1016\/j.bioorg.2024.107154_b0085","first-page":"3417","article-title":"Pharmacophore modeling, virtual screening, and molecular docking studies for discovery of novel Carbonic anhydrase IX inhibitors Med","volume":"21","author":"Lu","year":"2012","journal-title":"Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107154_b0090","article-title":"Exploration of 1,2,3-triazole linked benzenesulfonamide derivatives as isoform selective inhibitors of human carbonic anhydrase Bioorg","volume":"77","author":"Kakakhan","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0095","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.3109\/14756366.2016.1147438","article-title":"Synthesis and carbonic anhydrase I, II, IV and XII inhibitory properties of N-protected amino acid \u2013 sulfonamide conjugates","volume":"31","author":"K\u00fc\u00e7\u00fckbay","year":"2016","journal-title":"J Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114004","article-title":"Application of the dual-tail approach for the design and synthesis of novel Thiopyrimidine-Benzenesulfonamide hybrids as selective carbonic anhydrase inhibitors","volume":"228","author":"Abdel-Mohsen","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Expert Opin. Drug Disc."},{"key":"10.1016\/j.bioorg.2024.107154_b0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejmech.2018.05.034","article-title":"Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents","volume":"155","author":"Peerzada","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0115","doi-asserted-by":"crossref","first-page":"9768","DOI":"10.3390\/ijms24119768","article-title":"Novel 2-alkythio-4-chloro-N-[imino(heteroaryl)methyl]benzenesulfonamide Derivatives: Synthesis, Molecular Structure, Anticancer Activity and Metabolic Stability","volume":"24","author":"Zo\u0142nowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2024.107154_b0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejmech.2017.03.039","article-title":"Novel 2-benzylthio-5-(1,3,4-oxadiazol-2-yl)benzenesulfonamides with anticancer activity: Synthesis, QSAR study, and metabolic stability","volume":"132","author":"S\u0142awinski","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2016.05.025","article-title":"Indoles - a promising scaffold for drug development","volume":"91","author":"Sravanthi","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bioorg.2024.107154_b0130","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","article-title":"Chalcone: a privileged structure in medicinal chemistry","volume":"117","author":"Zhuang","year":"2017","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2024.107154_b0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bioorg.2018.11.003","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel 4-(2-aminoethyl)benzenesulfonamide-dipeptide conjugates","volume":"83","author":"K\u00fc\u00e7\u00fckbay","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0140","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1134\/S1068162019050108","article-title":"Synthesis, Molecular Docking, ADMET Studies, and Biological Evaluation of Isoxazoline and Pyrazoline Incorporating 1,2,3-Triazole Benzene Sulfonamides","volume":"45","author":"Siliveri","year":"2019","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.bjc.6603606","article-title":"A phase I and pharmacokinetic study of indisulam in combination with carboplatin","volume":"96","author":"Dittrich","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2024.107154_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128249","article-title":"Novel triazole-sulfonamide bearing pyrimidine moieties with carbonic anhydrase inhibitory action: Design, synthesis, computational and enzyme inhibition studies","volume":"48","author":"Manzoor","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107154_b0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3184\/174751918X15161933697853","article-title":"Synthesis and antiproliferative activity of novel 1,2,3-triazole-sulfonamide hybrids","volume":"42","author":"Li","year":"2018","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107154_b0160","doi-asserted-by":"crossref","unstructured":"H. Bretschneider and H. Rager Darstellung aromatischer Azidoverbindungen nach der Dutt-Wormallschen Reaktion. Monatshefte F\u00fcr Chemie. 81 (1950), pp. 970\u2013980. 10.1007\/BF00899340.","DOI":"10.1007\/BF00899340"},{"key":"10.1016\/j.bioorg.2024.107154_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105764","article-title":"Tail-approach based design and synthesis of metanilamide as human carbonic anhydrase I, II, IV and IX Inhibitors","volume":"123","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0170","doi-asserted-by":"crossref","first-page":"6","DOI":"10.22159\/ijpps.2019v11i6.32684","article-title":"Design, synthesis, molecular docking, admet studies and biological evaluation of pyrazoline incorporated 1, 2, 3-triazole benzene sulphonamides","volume":"11","author":"Siliveri","year":"2019","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2024.107154_b0175","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"238","author":"Hilvo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/14756366.2013.879656","article-title":"Synthesis and biological activity of novel thiourea derivatives ascarbonic anhydrase inhibitors","volume":"30","author":"Korkmaz","year":"2015","journal-title":"J. Enz. Inh. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0185","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME : a free web tool to evaluate pharmacokinetics, drug- likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107154_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2012.09.019","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings I","volume":"64","author":"Lipinski","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2024.107154_b0195","doi-asserted-by":"crossref","first-page":"128527","DOI":"10.1016\/j.molstruc.2020.128527","article-title":"Design, synthesis, biological evaluation, molecular docking, DFT calculations and in silico ADME analysis of (benz)imidazole-hydrazone derivatives as promising antioxidant, antifungal, and anti-acetylcholinesterase agents","volume":"1218","author":"Khodja","year":"2020","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2024.107154_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201700025","article-title":"Anti-Inflammatory Activity, and COX-1\/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles","volume":"350","author":"Faidallah","year":"2017","journal-title":"Arch. Pharm. Chem. Life Sci."},{"key":"10.1016\/j.bioorg.2024.107154_b0205","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.4161\/cc.25842","article-title":"Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: therapeutic implications","volume":"16","author":"Chadwick","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bioorg.2024.107154_b0210","doi-asserted-by":"crossref","first-page":"102978","DOI":"10.1016\/j.bioorg.2019.102978","article-title":"Design and synthesis of new benzoxazole\/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents","volume":"89","author":"Philoppes","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0215","article-title":"Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions","author":"G\u00fcle\u00e7","year":"2023","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"10.1016\/j.bioorg.2024.107154_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105009","article-title":"Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors","volume":"113","author":"Askin","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107154_b0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bioorg.2024.107154_b0230","unstructured":"Schr\u00f6dinger Release 2017-3: Desmond Molecular Dynamics System; DE Shaw Research: New York, NY, USA; Maestro-Desmond Interoperability Tools, Schr\u00f6dinger: New York, NY, USA, 2017."},{"key":"10.1016\/j.bioorg.2024.107154_b0235","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jmgm.2009.02.003","article-title":"Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity","volume":"27","author":"Alam","year":"2009","journal-title":"J. Mol. Graph. Model."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824000592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:54:38Z","timestamp":1758617678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824000592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":47,"alternative-id":["S0045206824000592"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107154","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and in silico insights of novel 1,2,3-triazole benzenesulfonamide derivatives as potential carbonic anhydrase IX and XII inhibitors with promising anticancer activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107154"}}